// App-Quantinova.ai

313 : COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality

Researchers

Presenter

  • Alex Niu

Principal Investigators

  • Bo Ning

  • Francisco Socola

  • Hana Safah

  • Tim Reynolds

  • Moayed Ibrahim

  • Firas Safa

  • Tina Alfonso

  • Alfred Luk

  • David M Mushatt

  • Tony Hu

  • Nakhle S. Saba

Medical Centers

  • Section of Hematology and Medical Oncology, Department of Medicine, Tulane University, New Orleans, LA

  • Department of Biochemistry & Molecular Biology, Tulane University, New Orleans, LA

  • Section of Infectious Disease, Department of Medicine, Tulane University, New Orleans, LA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hematological malignancies

  • Acute respiratory failure

  • Lymphocytopenia

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Azithromycin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved